Horvat, T. Z., Adel, N. G., Dang, T., Momtaz, P., Postow, M. A., Callahan, M. K., . . . Chapman, P. B. (2015). Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol.
Citación estilo ChicagoHorvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects On Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab At Memorial Sloan Kettering Cancer Center." J Clin Oncol 2015.
Cita MLAHorvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects On Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab At Memorial Sloan Kettering Cancer Center." J Clin Oncol 2015.